Nephron and Clemson to Develop Robotics for Syringe Filling

August 15, 2019

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletter, Pharmaceutical Technology\'s In the Lab eNewsletter-09-04-2019, Volume 14, Issue 9

Nephron Pharmaceuticals is partnering with Clemson University to create a robotic solution for syringe-filling automation to enhance sterile manufacturing.

Nephron Pharmaceuticals Corporation, which is based in West Columbia, SC, announced on Aug. 12, 2019, that the company is partnering with Clemson University to create a robotic solution for syringe-filling automation. The robotics research is being done to enhance sterile manufacturing to keep up with supply demand. The technology will support the Nephron 503B Outsourcing Facility, a cGMP manufacturer providing sterile, prefilled medications.

The partnership is Nephron's first with the University and was developed through External Affairs' Office of Corporate Partnerships and Strategic Initiatives at Clemson. "Industry needs are changing at a rapid rate, and Clemson is equipped to support companies like Nephron. Together, we have created a mutually beneficial project to enhance their capabilities while providing the University's students with unique, hands-on research experience," said Angie Leidinger, vice-president for External Affairs, in the press release. 

Clemson College of Engineering, Computing, and Applied Science professor and researcher Yue "Sophie" Wang, mechanical engineering doctoral student Brandon Delspina, and mechanical engineering master's student Yu "Gloria" Zhang are performing the robotics research. 

Source: Nephron